COMPLIANCE POLICY GUIDE (CPG)
CPG Sec 585.225 Black-Eyed Peas (Cow Peas, Field Peas); Dried-Adulteration with Lygus Bug Damage March 1995
The following represents the criteria for direct reference seizure *requests to the Office of Human and Animal Food Operations (OHAFO) in consultation with the Office of Enforcement and Import Operations (OEIO) and CFSAN, and for direct citation by the appropriate Field Office within the Human and Animal Food Program*:
The dried black-eyed peas contain an average of 10% or more by count of class 6 damage or higher, minimum of 12 subsamples examined.
NOTE: See FDA Technical Bulletin No. 5 - Macroanalytical Procedures Manual, V-116 for classification of black-eyed peas damaged by lygus bug.
REMARKS:
If there is reason to believe the lot was graded and certified by the U.S. Department of Agriculture, submit the following information via EMS or FAX to *CFSAN/Office of Field Programs/Division of Enforcement (HFS-605)* and await reply before proceeding:
Sample Number Date of Shipment
Article Involved Dealer
Amount of Lot Shipper
Codes Analytical Conclusions
SPECIMEN CHARGE:
The article was adulterated when introduced into and while in interstate commerce, and is adulterated while held for sale after shipment in interstate commerce within the meaning of said Act 21 U.S.C. 342(a)(3) in that it consists in part of a filthy substance by reason of the presence therein of insect damaged peas.
NOTES:
1. If the evidence establishes that the article became adulterated after receipt in interstate commerce, then charge only that the article "is adulterated while held for sale after shipment in interstate commerce."
2. If the evidence does not establish where the article became adulterated and the violation is such that it could have occurred anywhere, i.e. it is not a manufacturing defect, then also charge only that the article "is adulterated while held for sale after shipment in interstate commerce."
*Material between asterisks is new or revised.*
Issued: 11/7/79
Reissued: 10/1/80
Revised: 12/8/88, 3/95
Submit Comments
Submit comments on this guidance document electronically via docket ID: FDA-2013-S-0610 - Specific Electronic Submissions Intended For FDA's Dockets Management Staff (i.e., Citizen Petitions, Draft Proposed Guidance Documents, Variances, and other administrative record submissions)
If unable to submit comments online, please mail written comments to:
Dockets Management
Food and Drug Administration
5630 Fishers Lane, Rm 1061
Rockville, MD 20852
All comments should be identified with the title of the guidance.